ALAMEDA, Calif.--(BUSINESS WIRE)--Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, will hold its quarterly conference call to discuss year-end results on Wednesday, February 6, 2008, at 1:00 p.m. ET (10:00 a.m. PT). Kenneth Chahine, Chief Executive Officer, and Michael Coffee, Chief Business Officer, can be heard by calling 888-713-4205 (U.S.) or 617-213-4862 (non-U.S. locations) using passcode 16083697.
